ALMS
Alumis Inc
NASDAQ: ALMS · HEALTHCARE · BIOTECHNOLOGY
$24.69
+7.86% today
Updated 2026-04-30
Market cap
$2.91B
P/E ratio
—
P/S ratio
121.06x
EPS (TTM)
$-2.86
Dividend yield
—
52W range
$3 – $31
Volume
1.5M
Alumis Inc (ALMS) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Total assets | $108.17M | $89.61M | $340.99M |
| Cash & equivalents | $25.61M | $46.00M | $169.53M |
| Current assets | $102.56M | $53.36M | $306.19M |
| Total liabilities | $303.41M | $428.87M | $80.89M |
| Current liabilities | $13.35M | $20.87M | $50.91M |
| Long-term debt | — | — | — |
| Shareholder equity | $-195.24M | $-339.26M | $260.10M |
| Retained earnings | $-209.32M | $-364.32M | $-658.55M |
| Accounts receivable | $500000.00 | $722000.00 | $1.81M |
| Inventory | — | $-95000.00 | — |
| Goodwill | — | — | — |